“…Presently, the most common site used for the extraocular diversion of aqueous humor using glaucoma drainage devices is the subconjunctival space 8–10,12,14,18 . In attempts to prevent fibrosis and early implant failure, studies have focussed on (1) diverting aqueous humor from the anterior chamber to sites other than subconjunctivally; 11,14,19,20 (2) the biocompatibility of the material forming the implant, 1,14,21 and (3) using antimetabolites such as mitomycin‐C and 5‐fluorouracil to suppress fibrosis 22–25 …”